Orbimed Advisors LLC Neuro Pace Inc Transaction History
Orbimed Advisors LLC
- $2.8 Billion
- Q2 2025
A detailed history of Orbimed Advisors LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 2,614,184 shares of NPCE stock, worth $23.9 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
2,614,184
Previous 3,406,335
23.26%
Holding current value
$23.9 Million
Previous $41.9 Million
30.43%
% of portfolio
1.04%
Previous 1.3%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
108Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Morgan Stanley New York, NY2.59MShares$23.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$21.1 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$12.6 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$12.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.15MShares$10.5 Million0.22% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $227M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...